Iribarren ME, et al. Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma. P2520. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Veel heterogeniteit in resistente NSCLC-tumoren
apr 2024 | Longoncologie
nov 2021 | Astma
nov 2023
mei 2023
nov 2022